000 00605ngm a22001697a 4500
008 230614b |||||||| |||| 00| 0 eng d
082 _a615.1901
_bPAT
100 _aPatel, Aarti H.
_9106145
245 _aRegulatory Considerations of Nitrosamine Impurities as Per EMA and USFDA Guidelines
260 _aAhmedabad
_bInstitute of Pharmacy, Nirma University
_c2023
300 _a34p
500 _aGuided by Dr. Priti Mehta
700 _aMoga, Akanksha D.
_991986
700 _aPandya, Khevana A.
_991987
856 _uhttp://10.1.7.192/jspui/handle/123456789/11768
942 _2ddc
_cCD
999 _c145956
_d145956